Christiane J Bruns
Christiane J Bruns
[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer] [0.03%]
可切除胰腺癌新辅助和辅助治疗的未来概念
Thomas Seufferlein,Christoph Michalski
Thomas Seufferlein
Pancreatic cancer still has a very unfavorable prognosis. This is true even for the comparably small group of patients (maximum 15%) who are diagnosed with a clearly resectable tumor. The article provides information on the current statemen...
[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy] [0.03%]
【ascoⅲ期nsclc治疗指南第四部分：辅助治疗指征】
Khosro Hekmat,Christiane J Bruns
Khosro Hekmat
Thomas Schmidt,Orlin Belyaev,Waldemar Uhl et al.
Thomas Schmidt et al.
The incidence of pancreatic ductal adenocarcinoma is continuously increasing and will become the second leading cause of cancer-related death in Europe and the USA by 2030. With a 5-year overall survival rate of less than 10% the prognosis ...
Johanna Betzler,Pompiliu Piso,Ralf-Dieter Hofheinz et al.
Johanna Betzler et al.
Utz Settmacher
Utz Settmacher